Showing results (581-590 of 2,563) with videos related to
Sort By:
Pageof 257
Drug Testing and Analysis|September 22, 2023
Determination of urinary deanol-N-oxide excretion profiles after ingestion of nutritional supplements containing deanolOliver Krug, Sven Guddat, Christian Görgens, et al.Drug Testing and Analysis|June 20, 2023
High-throughput untargeted screening of biotherapeutic macromolecules in equine plasma by UHPLC-HRMS/MS: Application to monoclonal antibodies and Fc-fusion proteins for doping controlJustine Pinetre, Vivian Delcourt, François Becher, et al.Drug Testing and Analysis|March 5, 2026
Characterization of Samples From a Seized Synthetic Drug Laboratory by Suspect and Nontarget Screening With LC-HRMS-Identification of Markers Indicating Changes in the Clandestine Manufacturing Process of Amphetamine via the Leuckart RouteMaximilian Greif, Tobias Frömel, Stephan Wagner, et al.Drug Testing and Analysis|February 26, 2026
Evaluation of Therapeutic Opioids in Skin-Derived Matrices (Sweat and Sebum) of Neonatal and Pediatric Patients and Their Role in Opioid Incorporation Into HairMax Polke, Florian Zapf, Julia T Scherer, et al.Drug Testing and Analysis|February 24, 2026
The MAIIA EPO Purification Gel Kit, 7D3-An Alternative Purification Kit for Screening and Confirmation Procedures. Validation for Serum and Plasma MatricesJ Hempel, D Schwenke, S Reimann, et al.Drug Testing and Analysis|February 19, 2026
Identification and Analysis of Lysergic Acid Diethylamide Analogs, 4-Benzoyl-N,N-Diethyl-7-Methyl-4,6,6a,7,8,9-Hexahydroindolo[4,3-fg]quinoline-9-Carboxamide (1Bz-LSD) and N,N-Diethyl-7-Methyl-4-(4-(Trimethylsilyl)Benzoyl)-4,6,6a,7,8,9-Hexahydroindolo[4,3-fg]quinoline-9-Carboxamide (1-TMSBz-LSD), in tablet or paper sheet products available online in JapanRie Tanaka, Maiko Kawamura, Michiho Ito, et al.Drug Testing and Analysis|February 19, 2026
Analytical Challenges in Detecting New Psychoactive Substances in Anti-Doping: A Proof-of-Concept Involving Pentedrone MetaboliteD Kwiatkowska, B Peta, K Grucza, et al.Drug Testing and Analysis|April 15, 2026
Identification and Characterization of the Designer Opioid N-Pyrrolidino Fluetonitazene in Nasal SprayFabian Picht, Valentin Cepus, Rona Hohlfeld, et al.Drug Testing and Analysis|April 5, 2026
Structural Characterization of 4-Fluorometomidate: A Novel Metomidate Derivative Detected in an E-CigaretteJialin Feng, Xin Wang, Miao Zhang, et al.Drug Testing and Analysis|March 18, 2026
Identification of Tetrahydrocannabinol (THC) Analogs, Including Methyl Ether Derivatives of THC and Hexahydrocannabiphorol, THC Methyl Carbonate and Its Synthetic by-Product, in Commercially Available Oil ProductsRie Tanaka, Michiho Ito, Ruri Kikura-HanajiriPageof 257